Table 1. Patient Demographic and Tumor Characteristics (Modified Intention-to-Treat Population).
Variable | LG (n = 119) | RG (n = 117) |
---|---|---|
Patient demographic characteristics | ||
Sex, No. (%) | ||
Male | 77 (64.7) | 73 (62.4) |
Female | 42 (35.3) | 44 (37.6) |
Age, median (range), y | 72 (40-90) | 71 (34-90) |
Institution, No. (%) | ||
Wakayama Medical University Hospital | 108 (90.8) | 109 (93.2) |
Mie University Hospital | 11 (9.2) | 8 (6.8) |
BMI, median (range) | 22.4 (14.0-31.9) | 21.9 (14.0-32.1) |
ASA score, No. (%) | ||
1 | 44 (37.0) | 39 (33.3) |
2 | 72 (60.5) | 74 (63.2) |
3 | 3 (2.5) | 4 (3.4) |
Comorbidity, No. (%) | ||
Hypertension | 62 (52.1) | 53 (45.3) |
Type 1 or 2 diabetes | 28 (23.5) | 20 (17.1) |
Pulmonary | 7 (5.9) | 10 (8.5) |
Cardiovascular | 13 (10.9) | 14 (12.0) |
Renal | 7 (5.9) | 4 (3.4) |
Hepatic | 2 (1.7) | 2 (1.7) |
Cerebrovascular | 16 (13.4) | 6 (5.1) |
History of abdominal surgery, No. (%) | 27 (22.7) | 32 (27.4) |
Open cholecystectomy | 4 (3.4) | 2 (1.7) |
Laparoscopic cholecystectomy | 3 (2.5) | 3 (2.6) |
Appendectomy | 14 (11.8) | 18 (15.4) |
Colorectal surgery | 3 (2.5) | 3 (2.6) |
Gynecological surgery | 7 (5.9) | 8 (6.8) |
Hepatectomy | 0 | 1 (0.9) |
Smoking history, Brinkman index, median (range) | 60 (0-2500) | 400 (0-4000) |
Daily drinker, No. (%) | 57 (47.9) | 48 (41.0) |
Tumor characteristics | ||
Location, No. (%) | ||
Upper third of the stomach | 24 (20.2) | 31 (26.5) |
Middle third of the stomach | 43 (36.1) | 35 (29.9) |
Lower third of the stomach | 50 (42.0) | 46 (39.3) |
Whole stomach | 2 (1.7) | 5 (4.3) |
Size, median (range), mm | 32 (3-120) | 35 (8-150) |
Macroscopic type, No. (%)a | ||
0 | 55 (46.2) | 57 (48.7) |
1 | 6 (5.0) | 4 (3.4) |
2 | 22 (18.5) | 20 (17.1) |
3 | 29 (24.4) | 30 (25.6) |
4 | 4 (3.4) | 5 (4.3) |
5 | 3 (2.5) | 1 (0.9) |
Histologic type, No. (%)a | ||
Pap | 1 (0.8) | 1 (0.9) |
Tub1 | 35 (29.4) | 32 (27.4) |
Tub2 | 34 (28.6) | 28 (23.9) |
Por | 42 (35.3) | 46 (39.3) |
Sig | 2 (1.7) | 6 (5.1) |
Muc | 2 (1.7) | 1 (0.9) |
Others | 3 (2.5) | 3 (2.6) |
pT stage, No. (%)b | ||
T1a | 23 (19.3) | 25 (21.4) |
T1b | 40 (33.6) | 43 (36.8) |
T2 | 14 (11.8) | 10 (8.5) |
T3 | 26 (21.8) | 25 (21.4) |
T4a | 15 (12.6) | 11 (9.4) |
T4b | 1 (0.8) | 3 (2.6) |
pN stage, No. (%)b | ||
N0 | 70 (58.8) | 76 (65.0) |
N1 | 24 (20.2) | 19 (16.2) |
N2 | 12 (10.1) | 15 (12.8) |
N3 | 13 (10.9) | 7 (6.0) |
pM stage, No. (%)b | ||
M0 | 111 (93.3) | 114 (97.4) |
M1 | 8 (6.7) | 3 (2.6) |
p Stage, No. (%)b | ||
IA | 52 (43.7) | 52 (44.4) |
IB | 19 (16.0) | 16 (13.7) |
IIA | 12 (10.1) | 18 (15.4) |
IIB | 9 (7.6) | 13 (11.1) |
IIIA | 9 (7.6) | 10 (8.5) |
IIIB | 5 (4.2) | 2 (1.7) |
IIIC | 5 (4.2) | 3 (2.6) |
IV | 8 (6.7) | 3 (2.6) |
Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); LG, laparoscopic gastrectomy; Muc, mucinous adenocarcinoma; Pap, papillary adenocarcinoma; Por, poorly differentiated adenocarcinoma; RG, robotic gastrectomy; Sig, signet-ring cell carcinoma; Tub1, well differentiated tubular adenocarcinoma; Tub2, moderately differentiated tubular adenocarcinoma.
Japanese Classification of Gastric Carcinoma.18
UICC 8th edition.17